lenvatinib and betulin

lenvatinib has been researched along with betulin* in 1 studies

Other Studies

1 other study(ies) available for lenvatinib and betulin

ArticleYear
SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway.
    Acta biochimica et biophysica Sinica, 2023, Jul-11, Volume: 55, Issue:9

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Mice; Phenylurea Compounds; TOR Serine-Threonine Kinases

2023
chemdatabank.com